Download Citation
Article Source:
Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
Szczepanek SM,
Roberts S,
Rogers K,
Cotte C,
Adami AJ,
et al.
(2016)
Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.
PLOS ONE 11(2): e0149261.
https://doi.org/10.1371/journal.pone.0149261